REGN Market Cap & Key Metrics
Regeneron Pharmaceuticals, Inc.
$748.80
+$10.08(+1.36%)
52
Overall
80
Value
20
Tech
57
Quality
Market Cap
$74.79B
Volume
191.58K
52W Range
$541.00 - $859.34
Target Price
$859.48
REGN market cap is $74.79B. This page lists Regeneron Pharmaceuticals, Inc.'s P/E ratio, EPS estimates, dividend yield, payout ratio and MarketXLS scores.
REGN Key Metrics
- Market cap
- $74.79B
- P/E ratio (current-year EPS estimate)
- 16.52
- EPS estimate, current year
- $45.34
- Dividend yield (TTM)
- 0.49%
- Payout ratio
- 8.7%
- EPS growth, 3-year
- +2.06%
- Value score
- 80
- Quality score
- 57
- Technical score
- 20
| Fiscal year | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Revenue | $14.34B | $14.20B | $13.12B | $12.17B | $16.07B |
| EBITDA | $5.82B | $5.32B | $4.69B | $5.26B | $9.67B |
| EPS | $43.07 | $40.90 | $37.05 | $40.51 | $76.40 |
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Vol |
| 2 | REGN | $748.80 | +1.4% | 191.58K |
| 3 | ||||
| 4 | ||||
| 5 | ||||
| 6 |
Get Regeneron Pharmaceuticals, Inc. Data in Excel
Stream real-time data directly to your spreadsheets
BUY NOW